SETTING Five districts across five states of India. OBJECTIVE To assess the prevalence of TB-associated disability, comorbidities, risk determinants, and linkage to care among adults completing TB treatment between October 2024 and December 2025. DESIGN A cohort study using primary data collection. Trained research staff conducted all the assessments. Pulmonary disability meant impaired lung function on spirometry and/or walking <400 m on 6-minute walk test. Linkage to care was assessed through telephonic follow-up after a month of referral. RESULTS Of 780 participants, 85% had at least one comorbidity, risk determinant, or disability (multimorbidity). The prevalence of pulmonary disability was 60% (95% confidence interval: 56–64). Undernutrition (36%), diabetes (24%), and hypertension (19%) were the most common comorbidities, with 13% of diabetes and 55% of hypertension being newly detected. Pulmonary disability was associated with older age, pulmonary TB, undernutrition, mental health disorder, smoking, and silica exposure. Referral ranged from 12% to 100% for various conditions, with low rates for mental health disorders (12%) and recreational drug use (33%). CONCLUSION Successful completion of TB treatment and bacteriological cure does not imply restoration of health-related quality of life. Early integration of patient-centred care for multimorbidity is essential for restoring health among TB survivors.
No takes yet. Share an insight, caveat, or question.
Subramanian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: